Statement of the ASFV Committee on Ruling in Delaware

NEW YORK, Nov. 01, 2022 (GLOBE NEWSWIRE) -- Jonathan Jorgl, an AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM”) stockholder, together with his nominees,...

Related Keywords

Delaware ,United States ,New Jersey ,Broadacres ,American ,Jonathan Jorgl ,Robertl Chioini ,Michael Rice ,Exchange Commission ,Delaware Court ,Alliance Advisors ,Immunotech Inc ,Stockholder Full Value Committee ,Full Value ,Aim Stockholder Full Value Committee ,